期刊文献+

胆固醇代谢在肝细胞癌发生发展中的作用研究进展 被引量:3

Research progress of cholesterol metabolism disorder in hepatocellular carcinoma
原文传递
导出
摘要 肝细胞癌(HCC)是常见的恶性实体瘤,其发病率高,预后差。尽管病毒性肝炎仍是HCC的最主要病因,近年来随着生活水平的提高和膳食习惯的改变,非酒精性脂肪性肝病正成为HCC不可忽视的病因。新近研究表明,胆固醇代谢紊乱在HCC的发生、发展中扮演着重要的角色。采用各种方法干预胆固醇代谢紊乱,能够有效的预防和治疗HCC。本文通过对近年相关研究进行文献回顾,就胆固醇代谢紊乱在HCC的发生发展中的作用研究进展进行综述。 Hepatocellular carcinoma(HCC)is a common malignant solid tumor with high incidence rate and poor prognosis.Although viral hepatitis is still the main cause of HCC,in recent years,with the improvement of living standards and the change of dietary habits,non-alcoholic fatty liver disease is becoming an important cause of HCC.Recent studies have shown that cholesterol metabolism disorder plays an important role in the occurrence and development of HCC.Using various methods to intervene cholesterol metabolism disorder can effectively prevent and treat HCC.This paper reviews the literature on the role of cholesterol metabolism disorder in the occurrence and development of HCC.
作者 谭智 徐志伟 袁观斗 吕军 何松青 Tan Zhi;Xu Zhiwei;Yuan Guandou;Lyu Jun;He Songqing(Department of Hepatobiliary Surgery,the First Affiliated Hospital of Guangxi Medical University,Nanning 530021,China;Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor(Guangxi Medical University),Ministry of Education,Nanning 530021,China;Guangxi Key Laboratory of Immunology and Metabolism for Liver Diseases,Nanning 530021,China)
出处 《中华实验外科杂志》 CAS 北大核心 2022年第4期788-791,共4页 Chinese Journal of Experimental Surgery
基金 国家自然科学基金(91949122、82160500) 广西重点研发计划项目(2018AD03001) 111计划(D17011) 中央引导地方科技发展专项(ZY20198011) 广西八桂学者(何松青)广西医科大学第一附属医院肝脏损伤与修复重点实验室培育项目(YYZS2020001) 区域性高发肿瘤早期防治研究教育重点实验室自主课题(GKE-ZZ202105、GKE-ZZ202112、GKE-ZZ202139)。
关键词 胆固醇 肝细胞癌 非酒精性脂肪性肝炎 Cholesterol Hepatocellular carcinoma Non-alcoholic steatohepatitis
  • 相关文献

参考文献4

二级参考文献21

  • 1Raffi Karagozian,Zoltán Derdák,Gy?rgy Baffy.Obesity-associated mechanisms of hepatocarcinogenesis[J]. Metabolism . 2014
  • 2Bernd Schnabl,David A. Brenner.Interactions Between the Intestinal Microbiome and Liver Diseases[J]. Gastroenterology . 2014
  • 3Samuel Buck S,Shaito Abdullah,Motoike Toshiyuki,Rey Federico E,Backhed Fredrik,Manchester Jill K,Hammer Robert E,Williams S Clay,Crowley Jan,Yanagisawa Masashi,Gordon Jeffrey I.Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41[].Proceedings of the National Academy of Sciences of the United States of America.2008
  • 4L. K. Brahe,A. Astrup,L. H. Larsen.Is butyrate the link between diet, intestinal microbiota and obesity‐related metabolic diseases?[J]. Obes Rev . 2013 (12)
  • 5Diego Rincón,Javier Vaquero,Ana Hernando,Evelyn Galindo,Cristina Ripoll,Marta Puerto,Magdalena Salcedo,Rubén Francés,Ana Matilla,María V. Catalina,Gerardo Clemente,José Such,Rafael Ba?ares.Oral probiotic VSL #3 attenuates the circulatory disturbances of patients with cirrhosis and ascites[J]. Liver Int . 2014 (10)
  • 6Manish Kumar Lunia,Barjesh Chander Sharma,Praveen Sharma,Sanjeev Sachdeva,Siddharth Srivastava.Probiotics Prevent Hepatic Encephalopathy in Patients With Cirrhosis: A Randomized Controlled Trial[J]. Clinical Gastroenterology and Hepatology . 2014
  • 7Reiner Wiest,Melissa Lawson,Markus Geuking.Pathological bacterial translocation in liver cirrhosis[J]. Journal of Hepatology . 2014 (1)
  • 8Gyongyi Szabo.Gut–Liver Axis in Alcoholic Liver Disease[J]. Gastroenterology . 2014
  • 9S.M. O’Mahony,G. Clarke,Y.E. Borre,T.G. Dinan,J.F. Cryan.Serotonin, tryptophan metabolism and the brain-gut-microbiome axis[J]. Behavioural Brain Research . 2014
  • 10Graham J. Dockray.Gastrointestinal hormones and the dialogue between gut and brain[J]. J Physiol . 2014 (14)

共引文献1312

同被引文献25

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部